Back
Microsoft Corp. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Sell
46
MSFT
Microsoft Corp.
Last Price:
$478.48
Seasonality Move:
7.23%
Buy
60
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$30.66
Seasonality Move:
-6.94%
Sell
46
Microsoft Corp. (MSFT)
is a Sell
Is Microsoft Corp. a Buy, Sell or Hold?
-
The current Microsoft Corp. [MSFT] share price is $492.02. The Score for MSFT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MSFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $26.58. The Score for OLMA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MSFT Stock Price Chart
What is Microsoft Corp.'s stock price today?
-
The Microsoft Corp. share price today is $492.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing buying pressure, which is a positive indicator for future bullish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $26.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
MSFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.01 | Sell |
| Relative Strength Index (14 RSI): | 48.53 | Sell |
| Chaikin Money Flow: | 13884118 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (480.41 - 505.49) | Sell |
| Bollinger Bands (100): | (495.41 - 523.71) | Sell |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.6 | Buy |
| Relative Strength Index (14 RSI): | 74.25 | Buy |
| Chaikin Money Flow: | -585363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.87 - 27.45) | Buy |
| Bollinger Bands (100): | (3.4 - 17.02) | Buy |
MSFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 486.69 | Buy |
| 20-day SMA: | 490.11 | Buy |
| 50-day SMA: | 506.93 | Sell |
| 200-day SMA: | 470.65 | Buy |
| 8-day EMA: | 486.99 | Buy |
| 20-day EMA: | 491.04 | Buy |
| 50-day EMA: | 499.92 | Sell |
| 200-day EMA: | 480.77 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.51 | Sell |
| 20-day SMA: | 21.26 | Buy |
| 50-day SMA: | 14.13 | Buy |
| 200-day SMA: | 7.33 | Buy |
| 8-day EMA: | 26.63 | Sell |
| 20-day EMA: | 22.44 | Buy |
| 50-day EMA: | 16.3 | Buy |
| 200-day EMA: | 9.75 | Buy |
Microsoft Corp. Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.80 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
Microsoft Corp. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||